𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A review of the logistic role of l-carnitine in the management of radiation toxicity and radiotherapy side effects

✍ Scribed by Haseeb Ahmad Khan; Abdullah Saleh Alhomida


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
144 KB
Volume
31
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis


ABSTRACT

Radiation therapy is a key modality in the treatment of different cancer types. Fatigue is the most common side effect of radiotherapy, while others include nausea, hair loss, skin irritation, anemia, infertility, cardiovascular disease, cognitive impairment and even the development of second cancers. Studies in experimental animals have shown protective effects of carnitine against exposure of various organs to ionizing radiation, whereas carnitine deficiency is known to enhance radiation‐induced toxicity. This report summarizes the recent literature on the adverse effects of radiotherapy and the impact of radiation on carnitine homeostasis. Although some studies have demonstrated the prophylactic benefits of carnitine against the toxic effects of chemotherapy, the role of carnitine in the prognosis and management of cancer patients receiving radiotherapy is not clear and needs to be explored. Copyright Β© 2011 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Neuroprotective effects of acetyl-L-carn
✍ Lorenzo Di Cesare Mannelli; Carla Ghelardini; Menotti Calvani; Raffaella Nicolai πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 240 KB

## Abstract Several pathologies related to nervous tissue alterations are characterized by a chronic pain syndrome defined by persistent or paroxysmal pain independent or dependent on a stimulus. Pathophysiological mechanisms related to neuropathic disease are associated with mitochondrial dysfunct

The role of maternal toxicity in lovasta
✍ George R. Lankas; Mark A. Cukierski; L. David Wise πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 324 KB πŸ‘ 2 views

## Abstract The role of maternal toxicity in lovastatin‐induced developmental toxicity in rats was examined in a series of studies. The first study administered lovastatin at 100, 200, 400, or 800 mg/kg/day (mkd) orally to mated rats from Gestation Day (GD) 6 through 20. Maternal toxicity was obser